GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SKAN Group AG (CHIX:SKANz) » Definitions » Construction In Progress

SKAN Group AG (CHIX:SKANZ) Construction In Progress : CHF0.0 Mil (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is SKAN Group AG Construction In Progress?

SKAN Group AG's quarterly construction in progress increased from Jun. 2023 (CHF0.0 Mil) to Dec. 2023 (CHF24.6 Mil) but then declined from Dec. 2023 (CHF24.6 Mil) to Jun. 2024 (CHF0.0 Mil).

SKAN Group AG's annual construction in progress declined from Dec. 2021 (CHF18.6 Mil) to Dec. 2022 (CHF11.7 Mil) but then increased from Dec. 2022 (CHF11.7 Mil) to Dec. 2023 (CHF24.6 Mil).


SKAN Group AG Construction In Progress Historical Data

The historical data trend for SKAN Group AG's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SKAN Group AG Construction In Progress Chart

SKAN Group AG Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Construction In Progress
3.79 18.65 11.69 24.56

SKAN Group AG Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Construction In Progress Get a 7-Day Free Trial - 11.69 - 24.56 -

SKAN Group AG Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


SKAN Group AG Business Description

Traded in Other Exchanges
Address
Kreuzstrasse 5, Allschwil, CHE, 4123
SKAN Group AG is a global market and technological company for isolators, cleanroom devices, and decontamination processes for the aseptic production of biopharmaceutical substances. Its core competency is the design and development of process isolators for the aseptic filling of biopharmaceutical products. The company offer its customers process support, services, and consumables. Its products include biological indicators, isolators, Laboratory/cleanroom equipment, laminar flow, safety workbench, and transfer system. The Firm has three operating segment Equipment & solutions, Services & Consumables, and Other. The company generates the majority of its revenue from the Equipment & solutions segment. Geographically the company derives revenue from Asia, Europe, Americas, and Other regions.

SKAN Group AG Headlines

No Headlines